Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia

Blood

Volumn 90, Issue 4, 1997, Pages 1387-1394

  Thompson, Alexis A ^a   Talley, Jeaniene A ^b   Do, Ha Nancy ^b   Kagan, H Lee ^b   Kunkel, Lori ^b   Berenson, James ^b   Cooper, Max D ^b   Saxon, Andrew ^b   Wall, Randolph ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; IMMUNOGLOBULIN HEAVY CHAIN; LYMPHOCYTE RECEPTOR; MESSENGER RNA;

ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; GENE DELETION; GENE INSERTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030761477     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.4.1387     Document Type: Article

References (40)

1. O'Brien S, del Giglio A, Keating M: Advances in the biology and treatment of B-cell chronic leukemia. Blood 85:307, 1995
2. Rozman C, Montserrat E: Chronic lymphocytic leukemia. N Engl J Med 333:1052, 1995
3. Geisler CH, Philip P, Hansen MM: B-cell chronic lymphocytic leukaemia: Clonal chromosome abnormalities and prognosis in 89 cases. Eur J Haematol 43:397, 1989
4. Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, Mackie MJ, Parker AC, Castoldi GL, Guneo A, Knuutila S, Elonen E, Gahrton G: Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 323:720, 1990
5. Dighiero G, Travade P, Chevret S, Fenaux P, Chastang C, Binet JL: B-cell chronic lymphocytic leukemia: Present status and future directions. French Cooperative Group on CLL. Blood 78:1901, 1991
6. Geisler CH, Larsen JK, Hansen NE, Hansen MM, Christensen BE, Lund B, Nielsen H, Plesner T, Thorling K, Andersen E, Andersen PK: Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 78:1795, 1991
7. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC: bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82:1820, 1993
8. Johnstone AP: Chronic lymphocytic leukaemia and its relationship to normal B lymphopoiesis. Immunol Today 3:343, 1982
9. Pianezze G, Gentilini I, Casini M, Fabris P, Coser P: Cytoplasmic immunoglobulins in chronic lymphocytic leukemia B cells. Blood 69:1011, 1987
10. Burkhardt AL, Costa T, Misulovin Z, Stealy B, Bolen JB, Nussenzweig MC: Ig alpha and Ig beta are functionally homologous to the signaling proteins of the T-cell receptor. Mol Cell Biol 14: 1095, 1994
11. Costa TE, Franke RR, Sanchez M, Misulovin Z, Nussenzweig MC: Functional reconstitution of an immunoglobulin antigen receptor in T cells. J Exp Med 175:1669, 1992
12. Sanchez M, Misulovin Z, Burkhardt AL, Mahajan S, Costa T, Franke R, Bolen JB, Nussenzweig M: Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta. J Exp Med 178:1049, 1993
13. Torres RM, Flaswinkel H, Reth M, Rajewsky K: Aberrant B cell development and immune response in mice with a compromised BCR complex [see comments]. Science 272:1804, 1996
14. Papavasiliou F, Misulovin Z, Suh H, Nussenzweig MC: The role of Ig beta in precursor B cell transition and allelic exclusion. Science 268:408, 1995
15. Gong S, Nussenzweig MC: Regulation of an early developmental checkpoint in the B cell pathway by Ig beta. Science 272:411, 1996
16. van Noesel CJ, van Lier RA: Architecture of the human B-cell antigen receptors. Blood 82:363, 1993
17. Clark MR, Campbell KS, Kazlauskas A, Johnson SA, Hertz M, Potter TA, Pleiman C, Cambier JC: The B cell antigen receptor complex: Association of Ig-alpha and Ig-beta with distinct cytoplasmic effectors. Science 258:123, 1992
18. Lin J, Justement LB: The MB-1/B29 heterodimer couples the B cell antigen receptor to multiple src family protein tyrosine kinases. J Immunol 149:1548, 1992
19. Nakamura T, Kubagawa H, Cooper MD: Heterogeneity of immunoglobulin-associated molecules on human B cells identified by monoclonal antibodies, Proc Nat Acad Sci USA 89:8522, 1992
20. Wood WJ Jr, Thompson AA, Korenberg J, Chen XN, May W, Wall R, Denny CT: Isolation and chromosomal mapping of the human immunoglobulin-associated B29 gene (IGB). Genomics 16:187, 1993
21. Batata A, Shen B: Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia. A study of 242 cases. Cancer 70:2436, 1992
22. Thompson AA, Wood WJ Jr, Gilly MJ, Damore MA, Omori SA, Wall R: The promoter and 5′ flanking sequences controlling human B29 gene expression. Blood 87:666, 1996
23. Mason DY, Cordell JL, Brown MH, Borst J, Jones M, Pulford K, Jaffe E, Ralfkiaer E, Dallenbach F, Stein H, Pileri S, Gatter KC: CD79a: A novel marker for B-cell neoplasms in routinely processed tissue samples. Blood 86:1453, 1995
24. Verschuren MC, Comans-Bitter WM, Kapteijn CA, Mason DY, Brouns GS, Borst J, Drexler HG, van Dongen JJ: Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines. Leukemia 7:1939, 1993
25. Hashimoto S, Gregersen PK, Chiorazzi N: The human Ig-beta cDNA sequence, a homologue of murine B29, is identical in B cell and plasma cell lines producing all the human Ig isotypes. J Immunol 150:491, 1993
26. Hashimoto S, Chiorazzi N, Gregersen PK: The complete sequence of the human CD79b (Ig beta/B29) gene: Identification of a conserved exon/intron organization, immunoglobulin-like regulatory regions, and allelic polymorphism, Immunogenetics 40:145, 1994
27. Williams AF, Barclay AN: The immunoglobulin superfamilydomains for cell surface recognition. Annu Rev Immunol 6:381, 1988
28. Reth M: Antigen receptor tail clue [letter]. Nature 338:383, 1989
29. Wengler GS, Notarangelo LD, Berardelli S, Pollonni G, Mella P, Fasth A, Ugazio AG, Parolini O: High prevalence of nonsense, frame shift, and splice-site mutations in 16 patients with full-blown Wiskott-Aldrich syndrome. Blood 86:3648, 1995
30. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey J, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakuno K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayanath P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett C, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66, 1994
31. Rawlings DJ, Scharenberg AM, Park H, Wahl MI, Lin S, Kato RM, Fluckiger AC, Witte ON, Kinet JP: Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Science 271:822, 1996
32. Hashimoto S, Chiorazzi N, Gregersen PK: Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/B29) RNA transcripts in human B cells. Mol Immunol 32:651, 1995
33. Friedrich RJ, Campbell KS, Cambier JC: The gamma subunit of the B cell antigen-receptor complex is a C-terminally truncated product of the B29 gene. J Immunol 150:2814, 1993
34. Eccles DM, Russell SE, Haites NE, Atkinson R, Bell DW, Gruber L, Hickey I, Kelly K, Kitchener H, Leonard R, Lessells A, Lowry S, Miller I, Milner B, Steel M: Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group. Oncogene 7:2069, 1992
35. Cropp CS, Champeme MH, Lidereau R, Callahan R: Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted. Cancer Res 53:5617, 1993
36. Dobo KL, Giver CR, Eastmond DA, Rumbos HS, Grosovsky AJ: Extensive loss of heterozygosity accounts for differential mutation rate on chromosome 17q in human Iymphoblasts. Mutagenesis 10:53, 1995
37. Zomas AP, Matutes E, Morilla R, Owusu-Ankomah K, Seon BK, Catovsky D: Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b). Leukemia 10:1966, 1996
38. Okasakj M, Luo Y, Han T, Yoshida M, Seon BK: Three new monoclonal antibodies that define a unique antigen associated with prolymphocytic leukemia/non-Hodgkin's lymphoma and are effectively internalised after binding to the cell surface antigen. Blood 81:84, 1993
39. Tseng J, Eisfelder BJ, Clark MR: B-cell antigen receptor-induced apoptosis requires Ig-alpha and Ig-beta. Blood 89:1513, 1997
40. Berntorp E, Zettervall O: High expression of lymphocyte surface immunoglobulin in chronic lymphocytic leukaemia may be a bad prognostic sign. Scand J Haematol 34:213, 1985